Orally administered vaccine can protect millions from hepatitis B. Oral vaccines are both safer and less expensive than injections. Therefore, researchers are continuously pursuing ways to produce an oral vaccine that is sufficiently effective. Now, University of Copenhagen physicists have delivered virologists a “recipe” for improving vaccine drops using methods from the world of nanophysics.
Millions of people are infected with hepatitis B every year. Hundreds of thousands die. And small children are particularly at risk. Due to high cost and the stable environmental conditions required for vaccine storage, many people in developing countries are not vaccinated against this dangerous virus. As such, researchers have been working to produce a drop or powdered form of oral vaccine. Oral vaccinations are cheaper and more easily administered than injections. However, developing a sufficiently effective oral hepatitis B vaccine has so far eluded researchers.
A joint collaboration from physicists at the Niels Bohr Institute, a team of researchers from University of São Paulo together with the Butantan Institute has introduced a technique to the pharmaceutical world that just might do the trick and lead to an optimal oral Hepatitis B vaccine.
“We have used a technology commonly used in solid state physics to explore how the vaccine behaves within a particular type of encapsulation. This has yielded crucial information that would not otherwise have been achievable. When we scientists venture beyond our comfort zone and deploy each other’s knowledge across disciplines, entirely new possibilities can emerge,” says Heloisa Bordallo, an associate professor at the Niels Bohr Institute, and one of the two main authors of the research article just published in Scientific Reports.
Three dimensional insight
A major challenge of making an oral vaccine is to encapsulate it in a material that can endure the harsh conditions of our digestive system, to protect the vaccine from being destroyed before it reaches its intended destination in the body. The Danish research team’s collaborative partners in Brazil have long known that the silica-material SBA-15 is well-suited to encapsulate a hepatitis B vaccine. However, they did not know exactly how the material protected the vaccine. Nor were they certain about why their vaccine was not always completely effective.
This is where the team of Danish physicists came into the picture. Using a special technique that combines x-ray and neutron imaging, researchers at the Niels Bohr Institute were able to produce 3D images of the inside of the SBA-15 silica. It marked a crucial step in the use of this technique to develop pharmaceuticals. The imagery allows researchers to see how the vaccine behaves inside the silica, right down to the particle scale. Among other things, they were able to see that the vaccine had a tendency to clump within the silica, making it less effective.
“Now we know what makes the vaccine less effective, and how to optimize it. We know exactly how much vaccine should be put in the silica capsule for it to work best in the body and the clinical trials can be better interpreted,” explains Heloisa Bordallo.
No more swelling and inflammation
The vaccine is particularly promising for developing nations, explains the other main author, Martin K. Rasmussen, a former student at the Niels Bohr Institute and current doctoral student at DTU:
“Getting rid of needles being poked into the arms of little children is an advantage in and of itself. It also eliminates any need to sterilize needles and possible side effects such as swelling and infection. And, unlike the vaccine in use today, this type of vaccine needn’t be refrigerated. As such, costs will be reduced and the vaccine’s administration will be eased.”
The researchers hope that the 3D technology will also be used to develop oral vaccines against several other types of disease. The goal of the Danish researchers’ Brazilian collaborative partners is to produce a 6-in-1 oral vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B. The vaccine against diphtheria and tetanus is already being developed.
Learn more: Needleless vaccine will protect children from dangerous viruses
The Latest on: Oral vaccines
via Google News
The Latest on: Oral vaccines
- Covid oral pill could be ready by year-end: Pfizer CEOon May 3, 2021 at 12:32 am
"If clinical trials go well and the Food and Drug Administration (FDA) approves it, the drug could be distributed across the US by the end of the year," Bourla told CNBC.
- Pfizer Q1 Earnings Preview: Vaccine Sales In Focus As Stock Fails To Impresson May 3, 2021 at 12:02 am
Market Overview Analysis by Investing.com (Haris Anwar/Investing.com) covering: Pfizer Inc, Johnson & Johnson, AstraZeneca PLC ADR, BioNTech SE. Read Investing.com (Haris Anwar/Investing.com)'s latest ...
- Supreme Court refuses to ban media from reporting oral observations of judgeson May 2, 2021 at 11:59 pm
"The unfolding of the debate in the court of law is equally important and the media has a duty to report. It's not just our judgments that are significant," says Justice DY Chandrachud. A bench ...
- Trending Report on Oral Cholera Vaccine Market with Growth Strategies, Market Dynamics and Competitive Landscape 2028on May 2, 2021 at 11:22 pm
Global Oral Cholera Vaccine Market report has covered and analyzed the potential of Worldwide market Industry and provides statistics and information on market dynamics, market analysis, growth ...
- Israeli firm keen to produce oral vaccines in PHon May 2, 2021 at 3:00 pm
An Israel vaccine manufacturer has also proposed to establish a vaccine production facility in the country, adding to at least 4 firms that are already in discussion with the government. Secretary ...
- Helicopter to Distribute Rabies Vaccines Over Cape Codon May 2, 2021 at 12:27 pm
Don’t be alarmed by a low-flying helicopter over Cape Cod in the next month or so. Starting Monday, a helicopter will drop oral rabies vaccine baits intended for raccoons and other wildlife over ...
- Helicopter to drop rabies vaccines for wildlife over Cape Codon May 2, 2021 at 11:22 am
The oral vaccine baits, intended for raccoons and other animals, will be dropped over portions of Barnstable and Plymouth counties in Massachusetts.
- Helicopter to distribute rabies vaccines intended for raccoons over Cape Codon May 2, 2021 at 5:31 am
Starting Monday, a helicopter will drop oral rabies vaccine baits intended for raccoons and other wildlife over portions of Barnstable and Plymouth counties, the Cape Cod Times reports.
- Oral Vaccines Market to Witness Huge Growth by 2026 | PaxVax, Serum Institute of India, GSKon April 30, 2021 at 1:48 am
Stay up-to-date with Oral Vaccines Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. The Latest Released Oral Vaccines market study has ...
- What are The Major Factors Expected to Limit The Growth Of The Oral vaccine Market?on April 28, 2021 at 9:05 am
The global oral vaccine market is expected to exceed more than US$ 50 Billion by 2024 at a CAGR of 7% in the given ...
via Bing News